Plasbumin United States
United States

 Advanced Search

Print this Page
Talecris Albumin Safety. Donor Selection

People who donate plasma for the first time should be willing to spend from two to three hours at the donor center which will include initial testing, a comprehensive interview and a thorough medical examination.

First-time Donor
Every first-time donor undergoes an extensive screening program:

Medical Exam
Medical History
Check against the National Donor Deferral Registry (NDDR)
Two sequential screening and serological viral tests are conducted within a six-month period:

Human immunodeficiency virus (HIV)
Hepatitis B (HBV)
Hepatitis C (HCV)

Plasma donations are held until the test results are completed.

Repeat Donations Required
For additional safety, Talecris Biotherapeutics holds a donor's plasma until the donor returns for a second donation.

If a donor does not return to the center in 60 days, the donor's plasma is destroyed. This requirement for a repeat donation has increased plasma safety dramatically.1,2

Albumin vs Starch
Commitment to Safety

References

1.   Remington, Petteway SR Jr. Comprehensive pathogen safety management for Plasbumin. Pediatr Crit Care Med. 2001;2(suppl):S23-S27.
2.   Council of Europe, Public Health Committee. Human Plasma for Fractionation.1998. Resolution AP-CSP (98) 11.
Plasbumin® Home  |   Healthcare Professionals  |   Excipient Customers  |   Patients
Important Safety Information  |   Prescribing Information  |   Site Map  |   Glossary



Talecris Biotherapeutics
Contact Talecris    General Conditions of Use    Privacy Statement   
This site is intended for US residents only. Non-US residents can go to www.Talecris.com.
© 2010 Talecris Biotherapeutics


 

 

 

 

 

 

Update Flash